Share This Author
The National Institutes of Health chronic prostatitis symptom index: Development and validation of a new outcome measure
Urologic diseases in America project: benign prostatic hyperplasia.
While the number of outpatient visits for BPH increased consistently during the 1990s, there was a dramatic decrease in the use of transurethral prostatectomy, inpatient hospitalization and length of hospital stay for this condition in 2000.
Urologic diseases in America project: urolithiasis.
The cost of urolithiasis is estimated at almost $2 billion annually and it appears to be increasing with time despite a shift in inpatient to outpatient treatment and the emergence of minimally invasive treatment modalities, perhaps because the prevalence of stone disease is increasing.
Patient navigation: State of the art or is it science?
There was evidence of some degree of efficacy for patient navigation in increasing participation in cancer screening and adherence to diagnostic follow‐up care after the detection of an abnormality and less evidence regarding the efficacy of navigation in reducing either late‐stage cancer diagnosis or delays in the initiation of cancer treatment or improving outcomes during cancer survivorship.
Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity (Fact/GOG‐Ntx) questionnaire for patients receiving systemic chemotherapy
- E. Calhoun, E. Welshman, D. Cella
- Medicine, PsychologyInternational journal of gynecological cancer…
- 1 November 2003
The FACT/GOG-Ntx is a reliable and valid instrument for assessing the impact of neuropathy on health-related quality of life and the Ntx subscale significantly differentiated the two groups at baseline and 3- and 6-month follow-ups.
A National Patient Navigator Training Program
The data show that overall the post test scores improved from the pretest and having a high school education or greater or having more years of work experience were significantly related to improvements on the posttest.
The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network.
The National Institutes of Health chronic prostatitis symptom index was formally developed and psychometrically validated, and may be useful in clinical practice as well as research protocols.
The financial burden of cancer: estimates from a study of insured women with breast cancer.
- A. Arozullah, E. Calhoun, C. Bennett
- Medicine, Political ScienceThe journal of supportive oncology
- 1 May 2004
Estimates of the costs incurred by a cohort of breast cancer patients who were covered by private, Medicare, or Medicaid health insurance indicate that even among women with comprehensive health insurance policies, the financial burden of Breast cancer can be substantial.
Prevalence and incidence of interstitial cystitis in a managed care population.
The prevalence and incidence of interstitial cystitis is significantly higher for women and men than previously published estimates and men account for a higher proportion of patients with IC than has previously been recognized.
Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI)
- K. Propert, M. Litwin, the Chronic Prostatitis Collaborative Research Network
- Medicine, PsychologyQuality of Life Research
- 1 March 2006
The NIH-CPSI total score and pain and quality of life subscores are responsive to change over␣time and ROC curves identified a 6-point decline in the Institutes total score as the optimal threshold to predict treatment response.